Breaking News Instant updates and real-time market news.

UBER

Uber

$41.40 /

+0.94 (+2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49

Uber board director Ryan Graves intends to resign

According to a regulatory filing, Ryan Graves informed Uber Technologies of his intention to resign as a member of the company's board of directors, effective as of May 27, 2019, including any committees of the board of directors on which he serves. Graves' resignation was not the result of any disagreement between Graves and the company, its management, board of directors or any committee thereof, or with respect to any matter relating to the company's operations, policies or practices, according to the filing.

  • 30

    May

UBER Uber
$41.40 /

+0.94 (+2.32%)

05/23/19 New Street
Uber initiated with a Buy at New Street
05/21/19
Fly Intel: Top five analyst initiations
05/21/19 Consumer Edge
Uber initiated with an Equal Weight at Consumer Edge
05/21/19 Susquehanna
Uber initiated with a Neutral at Susquehanna

TODAY'S FREE FLY STORIES

Upgrade
Keysight Technologies upgraded to Buy from Neutral at Goldman Sachs » 05:24
08/13/20
08/13
05:24
08/13/20
05:24
KEYS

Keysight Technologies

$99.58 /

+0.775 (+0.78%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

05:21 Today Goldman Sachs
National Instruments initiated with a Neutral at Goldman Sachs
08/04/20
Fly Intel: Top five analyst initiations
08/04/20 Edward Jones
Keysight Technologies initiated with a Buy at Edward Jones
06/01/20 JPMorgan
JPMorgan upgrades Keysight to Overweight as 5G growth play
KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

Initiation
National Instruments initiated with a Neutral at Goldman Sachs » 05:21
08/13/20
08/13
05:21
08/13/20
05:21
NATI

National Instruments

$35.97 /

-0.08 (-0.22%)

, KEYS

Keysight Technologies

$99.58 /

+0.775 (+0.78%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NATI National Instruments
$35.97 /

-0.08 (-0.22%)

KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

NATI National Instruments
$35.97 /

-0.08 (-0.22%)

04/14/20 JPMorgan
National Instruments initiated with a Neutral at JPMorgan
03/03/20 RBC Capital
National Instruments initiated with a Sector Perform at RBC Capital
01/09/20 Baird
National Instruments upgraded to Outperform at Baird
01/09/20 Baird
National Instruments upgraded to Outperform from Neutral at Baird
KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

08/04/20
Fly Intel: Top five analyst initiations
08/04/20 Edward Jones
Keysight Technologies initiated with a Buy at Edward Jones
06/01/20 JPMorgan
JPMorgan upgrades Keysight to Overweight as 5G growth play
06/01/20 JPMorgan
Keysight Technologies upgraded to Overweight from Neutral at JPMorgan
NATI National Instruments
$35.97 /

-0.08 (-0.22%)

KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

NATI National Instruments
$35.97 /

-0.08 (-0.22%)

KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

KEYS Keysight Technologies
$99.58 /

+0.775 (+0.78%)

Recommendations
Moderna COVID vaccine price per dose lower than expected, says JPMorgan » 05:18
08/13/20
08/13
05:18
08/13/20
05:18
MRNA

Moderna

$69.60 /

+0.66 (+0.96%)

JPMorgan analyst Cory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$69.60 /

+0.66 (+0.96%)

MRNA Moderna
$69.60 /

+0.66 (+0.96%)

08/11/20 Piper Sandler
Government awards for Moderna validates vaccine promise, says Piper Sandler
08/06/20 Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
MRNA Moderna
$69.60 /

+0.66 (+0.96%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$69.60 /

+0.66 (+0.96%)

MRNA Moderna
$69.60 /

+0.66 (+0.96%)

MRNA Moderna
$69.60 /

+0.66 (+0.96%)

Hot Stocks
Genentech: FDA accepts sBLA for self-administration option for Xolair » 05:18
08/13/20
08/13
05:18
08/13/20
05:18
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Federal Bank chooses Fiserv to support first independent credit card launch » 05:14
08/13/20
08/13
05:14
08/13/20
05:14
FISV

Fiserv

$97.95 /

-0.23 (-0.23%)

Fiserv said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FISV Fiserv
$97.95 /

-0.23 (-0.23%)

FISV Fiserv
$97.95 /

-0.23 (-0.23%)

08/11/20 Morgan Stanley
Fiserv price target raised to $96 from $90 at Morgan Stanley
07/22/20 Barclays
Fiserv shares undervalued after 'clearing event,' says Barclays
07/14/20 Barclays
Fiserv pullback brings 'unique buying opportunity,' says Barclays
07/14/20 Goldman Sachs
Fiserv initiated with a Conviction Buy at Goldman Sachs
FISV Fiserv
$97.95 /

-0.23 (-0.23%)

FISV Fiserv
$97.95 /

-0.23 (-0.23%)

FISV Fiserv
$97.95 /

-0.23 (-0.23%)

General news
IEA cuts forecasts for global oil demand » 05:10
08/13/20
08/13
05:10
08/13/20
05:10

IEA cuts forecasts for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Week of 8/7 EIA Natural Gas Report to be released at 10:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
6-Month Bill Announcement to be released at 11:00  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
8-Week Bill Auction to be released at 11:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
4-Week Bill Auction to be released at 11:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
Week of 8/3 Money Supply to be released at 16:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
Week of 8/12 Fed Balance Sheet to be released at 16:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
Conference/Events
Seaport Global forest products analyst to hold analyst/industry conference call » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Analysts, along with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Aerie Pharmaceuticals management to meet virtually with Needham » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
AERI

Aerie Pharmaceuticals

$12.37 /

+0.12 (+0.98%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

08/07/20 Mizuho
Aerie Pharmaceuticals price target lowered to $27 from $29 at Mizuho
08/07/20 Piper Sandler
Aerie Pharmaceuticals price target lowered to $25 from $35 at Piper Sandler
06/01/20 Oppenheimer
Aerie Pharmaceuticals assumed with an Outperform at Oppenheimer
05/07/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $31 from $37 at H.C. Wainwright
AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

Conference/Events
Needham to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Virtual Digital Commerce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Maxim Group and M-Vest to co-host a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
AGRX

Agile Therapeutics

$2.41 /

-0.185 (-7.14%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DARE

Dare Bioscience

$1.18 /

-0.015 (-1.26%)

Leading Innovators in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DARE Dare Bioscience
$1.18 /

-0.015 (-1.26%)

AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

03/20/20 H.C. Wainwright
H.C. Wainwright 'strongly' reiterates Buy on Agile Therapeutics
02/19/20 Janney Montgomery Scott
Agile Therapeutics price target raised to $9 from $4 at Janney Montgomery Scott
02/18/20 H.C. Wainwright
Agile Therapeutics price target raised to $7 from $5 at H.C. Wainwright
02/18/20 RBC Capital
Agile Therapeutics price target raised to $8 from $5 at RBC Capital
BAYRY Bayer
$0.00 /

+ (+0.00%)

08/11/20 Deutsche Bank
Bayer price target lowered to EUR 82 from EUR 87 at Deutsche Bank
08/11/20 Berenberg
Bayer price target lowered to EUR 76 from EUR 86 at Berenberg
08/10/20 Morgan Stanley
Bayer price target lowered to EUR 83 from EUR 88 at Morgan Stanley
06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
DARE Dare Bioscience
$1.18 /

-0.015 (-1.26%)

04/27/20 Brookline
Dare Bioscience initiated with a Buy at Brookline
03/31/20 Roth Capital
Dare Bioscience price target lowered to $4 from $6 at Roth Capital
08/22/19 Aegis
Dare Bioscience initiated with a Buy at Aegis
AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DARE Dare Bioscience
$1.18 /

-0.015 (-1.26%)

  • 21
    Feb
BAYRY Bayer
$0.00 /

+ (+0.00%)

AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

General news
3-Month Bill Announcement to be released at 11:00  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
Conference/Events
CNS Pharmaceuticals to hold a webinar » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
CNSP

CNS Pharmaceuticals

$1.76 /

-0.09 (-4.86%)

CEO Climaco discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNSP CNS Pharmaceuticals
$1.76 /

-0.09 (-4.86%)

CNSP CNS Pharmaceuticals
$1.76 /

-0.09 (-4.86%)

12/04/19 Benchmark
CNS Pharmaceuticals initiated with a Speculative Buy at Benchmark
  • 08
    Nov
Conference/Events
Raymond James to hold a virtual summit » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Aspen Energy Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
William Blair to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

3rd Annual Insurance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Jobless Claims to be reported at 08:30 » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Week of 8/8 Jobless…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Cantor Fitzgerald security analysts hold an analyst/industry conference call » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Analysts provide a summer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
HNI Corporation management to meet virtually with Benchmark » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
HNI

HNI Corporation

$32.23 /

+0.05 (+0.16%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HNI HNI Corporation
$32.23 /

+0.05 (+0.16%)

HNI HNI Corporation
$32.23 /

+0.05 (+0.16%)

05/22/20 Benchmark
HNI Corporation initiated with a Buy at Benchmark
HNI HNI Corporation
$32.23 /

+0.05 (+0.16%)

Conference/Events
FDA Oncologic Drugs Advisory Committee to hold a virtual meeting » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
MESO

Mesoblast

$11.80 /

+0.42 (+3.69%)

The Committee discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
05/28/20 Ladenburg
Mesoblast price target raised to $15.25 from $13 at Ladenburg
05/28/20 H.C. Wainwright
Mesoblast price target raised to $21 from $14 at H.C. Wainwright
04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

Conference/Events
Needham to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Virtual Semi-Cap &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.